SCHEMBL7772

SCHEMBL7772

c1ncc2cn[nH]c2n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29359980 1.00
Hydrochloric Acid SCHEMBL311528 0.98 RET (0.43)
Hydrochloric Acid SCHEMBL310498 0.98 RET (0.43)
SCHEMBL30612360 0.98 RET (0.43)
Water SCHEMBL438450 0.98 RET (0.43)
SCHEMBL3882735 0.89 RET (0.38)
Acetamide SCHEMBL9934182 0.86 PIK3C3 (0.38)
SCHEMBL30202633 0.82
SCHEMBL32668610 0.79
SCHEMBL30495986 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4789 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12545682-B2 Heterocyclic derivatives as P2X7 receptor antagonists BREYE THERAPEUTICS APS (DK) 2026-02-10 US claimed
US-20250388599-A1 TRICYCLIC PI3K INHIBITOR COMPOUNDS AND METHODS OF USE GENENTECH INC (US) 2025-12-25 US claimed
EP-3590516-B1 ANTITUMOR-EFFECT ENHANCER USING PYRAZOLO[3,4-D]PYRIMIDINE COMPOUND TAIHO PHARMACEUTICAL CO LTD (JP) 2025-09-03 EP claimed
WO-2025111482-A1 COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS BEXSON BIOMEDICAL, INC. (US) 2025-05-30 WO claimed
EP-4090332-B1 COMPOSITIONS OF SUBSTITUTED PYRAZOLOPYRIMIDINES AND USES THEREOF KSQ THERAPEUTICS INC (US) 2025-03-12 EP claimed
EP-4262975-B1 HETEROCYCLIC DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS BREYE THERAPEUTICS APS (DK) 2025-03-05 EP claimed
US-12186320-B2 Therapeutic agent containing pyrazolo[3,4-d]pyrimidine compound as active ingredient TAIHO PHARMACEUTICAL CO., LTD. (JP) 2025-01-07 US claimed
EP-3845231-B1 THERAPEUTIC AGENT CONTAINING PYRAZOLO[3,4-D]PYRIMIDINE COMPOUND AS ACTIVE INGREDIENT TAIHO PHARMACEUTICAL CO LTD (JP) 2025-01-01 EP claimed
WO-2024175999-A2 BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF DUNAD THERAPEUTICS LTD. (GB) 2024-08-29 WO claimed
WO-2024175998-A1 BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF DUNAD THERAPEUTICS, LTD. (GB) 2024-08-29 WO claimed
WO-1990003370-A1 DERIVATIVES OF PYRAZOLO[3,4-d]PYRIMIDINE MICROPROBE CORPORATION (US) 1990-04-05 WO claimed
US-4904666-A Pyrazolo(3,4-d)pyrimidine compounds, compositions and method of use BOEHRINGER MANNHEIM GMBH (DE) 1990-02-27 US claimed
US-4871653-A DEVELOPING IN PRESENCE OF MERCAPTO POLYAZAINDENE PROMOTERS AND NUCLEATING QUATERNARY OR HYDRAZIDE-TYPE COMPOUNDS FUJI PHOTO FILM CO., LTD. (JP) 1989-10-03 US claimed
US-4511557-A CALF'S BLOOD DIAYSATE AS VASODILATION POTENTIATOR GAURI KAILASH KUMAR (DE) 1985-04-16 US claimed
EP-0106309-A2 Biologically active extracts, process for their manufacture, medicinal and cosmetical preparations comprising them, and their use as additives in foodstuffs and stimulants Gauri, Kailash Kumar, Dr. Prof. (DE) 1984-04-25 EP claimed
EP-0077372-A1 NEW DERIVATIVES OF PYRAZOLO(3,4-d)PYRIMIDINE, PREPARATION METHOD THEREOF AND REMEDY CONTAINING THEM Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 1983-04-27 EP claimed
WO-1982003626-A1 NEW DERIVATIVES OF PYRAZOLO(3,4-D)PYRIMIDINE,PREPARATION METHOD THEREOF AND REMEDY CONTAINING THEM GAURI KAILASH KUMAR 1982-10-28 WO claimed
EP-0063381-A1 Pyrazolo(3-4-d) pyrimidines, process for their preparation and pharmaceutical compositions containing them Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 1982-10-27 EP claimed
US-4286093-A 9-Cyclohexyl-2-alkoxy-9H-adenine process MEAD JOHNSON & COMPANY (US) 1981-08-25 US claimed
US-4001230-A ANTIBACTERIAL, ANTIPROTAZOAL ELI LILLY AND COMPANY (US) 1977-01-04 US claimed